Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities (Q48107128)
scientific article
Language:
Current Data About Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities
(P31) (Q13442814)
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P304) 1725-1728
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P407) (Q1860)

(P433) 12
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P478) 61
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P577) Monday, December 1, 2003
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P921) (Q161238)

(P1433) (Q1161692)
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P1476) "Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities" (language: en)
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

(P2093) Feldmann R
(P1545) 1
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

Denecke J
(P1545) 2
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

Grenzebach M
(P1545) 3
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

Schuierer G
(P1545) 4
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

Weglage J
(P1545) 5
(P248)
(P698) 14694037
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/14694037

other details
description scientific article

External Links
(P356) 10.1212/01.WNL.0000098881.95854.5F
(P698) 14694037